Digital Lifestyle Intervention for Lung Cancer Survivors
About this study
The aim of this study is to assess the efficacy of a digital lifestyle intervention in non-small cell lung cancer (NSCLC) survivors on health-related quality of life (HRQoL) over three months.
- Condition
- Non-Small Cell Lung Cancer (NSCLC)
- Tested
- Lifestyle
- Sponsor
- Kai-Uwe Schmitt, PhD, MEng, ICID
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 9
- Minimum age: 18 years
- Study condition: Non-Small Cell Lung Cancer (NSCLC)
- Age ≥ 18 years
- Diagnosis of non-small cell lung cancer (NSCLC)
- Estimated life expectancy of ≥ six months (judged by local investigators/responsible health professionals)
- Undergoing inpatient or outpatient rehabilitation OR completion of planned surgery, chemotherapy, or radiation therapy for NSCLC within the past 24 weeks
- Knowledge of German to understand study material and assessments
- Access to a cell phone or tablet
- Written informed consent
Exclusion 2
- Inability to provide informed consent
- Inability to participate in the intervention because of physical, cognitive, or safety reasons (judged by local investigators/responsible health professionals)
Where
4 sites, 4 recruiting
Klinik Barmelweid AG
Barmelweid, Switzerland
Zürcher RehaZentren | Klinik Davos
Davos, Switzerland
Berner Reha Zentrum AG
Heiligenschwendi, Switzerland
Zürcher RehaZentren | Klinik Wald
Wald, Switzerland
Contact
-
Anja Frei, PhD
+41 44 634 43 60 anja.frei@uzh.ch
Potential match only. Final eligibility is determined by the study team.